Roche Defeats Class Cert. Bid In Canadian Accutane Action

Law360, New York (July 3, 2013, 4:45 PM EDT) -- A Canadian court has refused to certify a class action against Hoffmann-La Roche Ltd. claiming the acne drug Accutane causes inflammatory bowel disease, saying the plaintiff had not demonstrated a causal link between the drug and the condition.

In a June 27 opinion, Judge Manon Savard denied certification to a proposed class of Quebec citizens who used Accutane and allegedly suffer from Crohn's disease, ulcerative colitis, proctitis, rectal bleeding or certain other bowel diseases. The plaintiff, Yann Lebrasseur, claimed Roche failed to warn Accutane users of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.